Research

DHS funds earmarked for explosives, drugs detection

South Dakota-based Synthetik Applied Technologies, LLC has secured a Department of Homeland Security (DHS) Small Business Innovation Research (SBIR) Program…

5 days ago

DHS funds earmarked for UAS counter research

The Department of Homeland Security (DHS) has earmarked over $1 million for research on countering potential unmanned aerial systems (UAS)…

6 days ago

NY Gov. Hochul announces $40 million Biodefense Commercialization Fund

New York Gov. Kathy Hochul announced Thursday that her state would open up a $40 million Biodefense Commercialization Fund to…

1 week ago

Report: 20 years after 9/11, America still not fully prepared for public health emergencies

A new report from Trust for America’s Health (TFAH) has found that 20 years after the September 11 attacks on…

2 weeks ago

Argonne National Lab collaborations yield better understanding of SARS-CoV-2 proteins

Thanks to collaborations with commercial and academic research partners alike, the Argonne National Laboratory has published new research showing the…

3 weeks ago

House bill proposes support for Americans affected by mysterious Havana Syndrome

A new House bill introduced by United States Reps. Mike Turner (R-OH), Jason Crow (D-CO), and Brad Wenstrup (R-OH) --…

3 weeks ago

Phase 3 trial begins for SK bioscience and GSK COVID-19 vaccine candidate

Approximately 4,000 people from all over the world will be enrolled in a Phase 3 trial of a combined SK…

3 weeks ago

New WHO compendium charts 24 technologies to help low-resource nations with priority diseases

The World Health Organization (WHO) released a compendium this week consisting of 24 innovative health technologies that could be used…

3 weeks ago

BARDA program seeks to expand development of digital health tools and at-home diagnostic tests

Thinking up ways to better address future public health emergencies, the Biomedical Advanced Research and Development Authority’s (BARDA) Division of…

3 weeks ago

NIH begins study of extra COVID-19 vaccine dose effects on people with autoimmune disease

The National Institutes of Health (NIH) began a Phase 2 clinical trial last week to investigate any antibody response generated…

3 weeks ago

NTI analysis recommends immediate action to manage use of AI in nuclear weapons systems

According to a new paper from the nonprofit Nuclear Threat Initiative (NTI), artificial intelligence in nuclear weapons systems is a…

3 weeks ago

HHS fills vacant public posts on tick-borne illness advisory group

New voices were added to the United States Department of Health and Human Services’ (HHS) Tick-Borne Disease Working Group this…

3 weeks ago

Phase 3 trial for INOVIO COVID-19 vaccine candidate authorized to proceed in Brazil

INOVIO received the green light for phase three of its INNOVATE Phase 2/3 clinical trial of INO-4800 last week, allowing…

3 weeks ago

Zalgen to supply Lassa Fever antibody testing kits for CEPI study in West Africa

The largest ever Lassa Fever study in West Africa secured the means of testing this week, thanks to a contract…

4 weeks ago

Trial data shows Johnson & Johnson COVID-19 booster shot provides sizeable antibody uptick

New data released by Johnson & Johnson this week showed that using its single-shot COVID-19 vaccine as a booster for…

4 weeks ago

Soligenix demonstrates filovirus vaccine platform capabilities for multiple heat stable candidates

Through publication of data in Vaccine, this week Soligenix showcased the capabilities of its filovirus vaccine platform to formulate and…

4 weeks ago

Bavarian Nordic begins Phase 2 clinical trial of COVID-19 booster vaccine

A 210-person Phase 2 clinical trial for the COVID-19 vaccine candidate, ABNCoV2, began this week to determine its potential as…

4 weeks ago

Astra-Zeneca COVID-19 antibody therapeutic shows promise in Phase 3 trial

Results of a Phase 3 clinical trial have shown that AstraZeneca’s antibody combination for COVID-19, AZD7442, cuts the risk of…

4 weeks ago

WHO forms new advisory group on origins of novel pathogens

With the formation of a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), the World Health Organization…

4 weeks ago

Congressional watchdog: HHS, DHS, DOD, USDA must mutually prepare for biological threats

While key federal agencies prepared interagency response plans and conducted 74 interagency exercises from 2009 through 2019 to prepare for…

1 month ago

Soligenix filovirus vaccine candidates prove effective, heat stable in preclinical data

According to preclinical data produced by Soligenix, Inc. this week, positive, effective results have been demonstrated by multiple filovirus vaccine…

1 month ago

CDC to launch new center for disease outbreak forecasting, public health data access

Utilizing initial funding from the American Rescue Plan, the U.S. Centers for Disease Control and Prevention (CDC) unveiled plans this…

1 month ago

DHS releases parameters of proposed NYC airflow study

The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) recently composed an Environmental Assessment draft regarding a…

1 month ago

FEMA resource examines natural hazard risks

Federal Emergency Management Agency (FEMA) announced this week that it has launched the National Risk Index, designed to provide guidance…

1 month ago

NIH to invest $53M in five-year funding for HIV cure research

The National Institutes of Health (NIH) announced this week that it will award approximately $53 million in annual funding across…

1 month ago

CEPI to provide up to $20.6M to Gritstone bio for mRNA COVID-19 variant vaccine

As part of a new agreement with Gritstone bio, Inc., the Coalition for Epidemic Preparedness Innovations (CEPI) will provide up…

1 month ago

Preclinical data shows higher antibody action from CureVac, GSK’s second-generation mRNA COVID-19 vaccine candidate

A preclinical study conducted on non-human primates and published this week showed potential in a second-generation mRNA COVID-19 vaccine candidate,…

1 month ago

NIH scientists produce simpler, faster and cheaper means of COVID-19 testing

With diagnostic testing as important as ever in the battle to contain COVID-19, researchers from various institutions under the umbrella…

1 month ago

Valneva initiates COVID-19 vaccine candidate third phase

The specialty vaccine firm Valneva SE has initiated a Phase 3 trial for its COVID-19 vaccine candidate, VLA2001. VLA2001-304 seeks…

1 month ago

GAO issues NNSA lithium activity recommendations

The Government Accountability Office (GAO) has issued seven recommendations to the National Nuclear Security Administration (NSSA) regarding lithium activities. The…

1 month ago

New Moderna vaccine study shows antibodies maintain against variants for six months

According to a new manuscript published in Science last week, the majority of people given Moderna Inc.’s COVID-19 vaccine maintained…

1 month ago

DARPA selects three teams to develop novel therapeutics through HEALR program

The Defense Advanced Research Projects Agency recently selected three teams to support the Harnessing Enzymatic Activity for Lifesaving Remedies (HEALR)…

1 month ago

New vaccine recommendation, infection study address COVID-19, pregnancy

Groups of medical experts this week proposed a standardized definition for defining and evaluating placental SARS-CoV-2 infections to optimize both…

1 month ago

INO-4800 COVID-19 vaccine to undergo two trials for heterologous boosting in China

Regulatory approval was granted for two new clinical trials of INO-4800 in China this week, allowing its creator INOVIO and…

1 month ago

Integrum Scientific, CEPI partner to create Rift Valley fever vaccine international standard

A new partnership announced last week between Integrum Scientific and the Coalition for Epidemic Preparedness Innovations (CEPI) will advance progress…

1 month ago

This website uses cookies.